Kite Pharma, Inc.
Kite Pharma, Inc. is listed as the manufacturer on 2 FDA drug label records covering 2 distinct active ingredients predominantly cellular therapy products.
About Kite Pharma, Inc.
Kite Pharma, Inc. is named as the labeler on 2 FDA drug label records. Its catalogue spans 2 distinct active ingredients, led by AXICABTAGENE CILOLEUCEL, BREXUCABTAGENE AUTOLEUCEL. Most of these labels are cellular therapy products. Labelling across this portfolio most often references: b-cell lymphoma, adult patients, relapsed refractory, first-line chemoimmunotherapy, lines systemic, mantle cell, acute lymphoblastic, directed genetically. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.
Active ingredients in this portfolio
| Active ingredient | Products |
|---|---|
| AXICABTAGENE CILOLEUCEL | 1 |
| BREXUCABTAGENE AUTOLEUCEL | 1 |
Dosage forms and routes
| Dosage form | Products | Route | Products |
|---|---|---|---|
| — | — | INTRAVENOUS | 2 |
| — | — | — | — |
| — | — | — | — |
| — | — | — | — |
| — | — | — | — |
| — | — | — | — |
FDA drug products from Kite Pharma, Inc.
Frequently asked questions
How many FDA drug products does Kite Pharma, Inc. make?
2 FDA drug label records name Kite Pharma, Inc. as the manufacturer, covering 2 distinct active ingredients.
What active ingredients does Kite Pharma, Inc. produce?
The most frequent active ingredients in this portfolio are AXICABTAGENE CILOLEUCEL, BREXUCABTAGENE AUTOLEUCEL.
Are Kite Pharma, Inc. products prescription or over-the-counter?
The largest share of this company’s labels are cellular therapy products; check each product page for its own marketing status.
Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.
Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.